Lv44
470 积分 2024-05-10 加入
Tumor-Targeted Delivery of IL-2 by Fusing with a pH Low Insertion Peptide for Antitumor Immunotherapy
2小时前
已完结
Cancer therapy with antibodies
1个月前
已完结
Engineering interferons and interleukins for cancer immunotherapy
2个月前
已完结
Strategies to therapeutically modulate cytokine action
3个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
3个月前
已完结
The present and future of bispecific antibodies for cancer therapy
5个月前
已完结
皖公网安备34019202002308
